Can Erythropoietin Therapy Improve Survival?
Author:
Publisher
S. Karger AG
Subject
Cancer Research,Oncology,General Medicine
Reference29 articles.
1. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.
2. Pathological Response to Preoperative Chemoradiation Worsens with Anemia in Non---Small Cell Lung Cancer Patients
3. Anemia in cervical cancers: Impact on survival, patterns of relapse, and association with hypoxia and angiogenesis
4. Van Belle SJ, Cocquyt V: Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy. Crit Rev Oncol/Hematol 2003;47:1-11.
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Kombination Radio(chemo)therapie beim Lungenkarzinom – Nebenwirkungsmanagement;best practice onkologie;2023-10-10
2. The Use of Erythropoiesis-Stimulating Agents in Patients With CKD and Cancer: A Clinical Approach;American Journal of Kidney Diseases;2019-11
3. Erythropoiesis-Stimulating Agents and Cancer: Myth or Truth;Advances in Chronic Kidney Disease;2019-07
4. Erythropoese stimulierende Pharmaka (ESP);Transfusionsassoziierte Pharmakotherapie;2015-12-12
5. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy;Journal of Diabetes and its Complications;2012-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3